HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > RNCOS

Print e mail rss del Y! myWeb Tweet
 

Improved Regulations to Boost Russian Clinical Trial Industry

The current changes in the regulatory system will drive growth in the Russian clinical trial industry, says a news research by RNCOS.

 



(EMAILWIRE.COM, June 28, 2010 ) New Delhi, India - The Russian clinical trial industry has been registering strong growth for the last ten years. During this time period, the number of foreign sponsors in the Russian clinical trial industry has almost tripled. The key factor behind this high growth is - high patient recruitment rate. The recruitment rate is expected to grow in coming years on the back of current changes in regulations. As per our new research report “Clinical Trials Market in Russia”, the number of clinical trials in Russia is projected to grow at a CAGR of more than 7.5% during 2010-2012.

The new regulation has mandated insurance for all participants. This move is likely to attract more patients towards clinical trials and raise the number of patient enrollments. Besides, the increasing efforts to improve the quality of clinical sites and participants will also result into the high patient enrollments. In this regard, the report tries to find out all possible reasons fueling growth in the patient enrollments.

We have found that the cost has become an important factor responsible for growth in the clinical trial industry in emerging countries. Our report gives complete information and analysis of the cost factor in the Russian clinical trial industry. The report also studies and analyzes current industry trends and drivers propelling the overall industry growth.

“Clinical Trials Market in Russia” is a comprehensive report that contains quality research, in-depth analysis and authentic statistics of the clinical trials market in Russia. It studies the emerging market trends, recent developments and their impact on the market. The report will help clients to analyze the leading-edge opportunities, prospective customer base, key players, future outlook and all the other factors critical to the success of a new entrant in the clinical trials market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM189.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012